EdiGene and Arbor Biotechnologies Partnered to Advance Programs for Ex Vivo Engineered Cell Therapy
EdiGene, a biotechnology company that is focused on the translation of the gene-editing technologies into the transformative therapies for the patients suffering from cancer and different genetic disorders has partnered with Arbor Biotechnologies, a biotechnology company developing and discovering the next generation of the genetic medicines for the purpose of accessing the proprietary CRISPR gene […]
Continue Reading